What We Dispense


Multiple Sclerosis (MS)

Multiple sclerosis is a disease of the central nervous system in which the body’s immune system attacks the protective sheath (myelin) that covers the nerves. Damage to the myelin disrupts the flow of information in the brain and between the brain and the body. In some patients, the nerves may deteriorate and the irreversible damage can affect sensory and motor skills such as eyesight and walking.

HPC provides specialty medications for the treatment of multiple sclerosis – including the latest, most advanced drugs that focus on disease-modifying versus symptomatic treatment. Our HPC complete system of care is vital for patients with multiple sclerosis and other chronic medical conditions, providing them with access to services that support improved quality of life and the best possible medical outcomes.

Multiple Sclerosis Types and Specialized Treatment

Multiple sclerosis affects an estimated 2.5 million people worldwide. A disorder of young adults, the disease predominantly targets women with varying levels of severity and symptoms that range from fatigue and mood disturbances to pain, cognitive loss, and motor or sensory impairment.

There are several multiple sclerosis subtypes. Up to 75% of cases begin with a relapsing-remitting (RRMS) course, which involves acute attacks that are separated in time, with full or partial recovery. The primary-progressive (PPMS) subtype involves a progression of disability with occasional plateaus and temporary minor improvements. Approximately 6-10% of people with multiple sclerosis appear to have PPMS at diagnosis. The secondary-progressive (SPMS) subtype is characterized by progression of the disease at a variable rate.

The cause of the disease is unknown, but it is believed that environmental factors or an infection can trigger multiple sclerosis in an individual who is genetically predisposed to respond.

While no therapy has shown to cure the disease, multiple sclerosis treatments can help manage the disease. The assessment of therapies remains difficult because of the lack of specific indicators for disease activity and unpredictable disease course, however, the goals are consistent in attempting to decrease the severity and duration of attacks, halt or reverse the disease, or provide symptomatic relief from complications of the disease. Types of multiple sclerosis treatment include a new focus on disease-modifying therapies, immunomodulators, corticosteroids, and other immunosuppressants.

HPC offers the following drug therapies – including advanced biologics – for multiple sclerosis treatment:

  • Avonex®
  • Betaseron®
  • Copaxone®
  • Extavia®
  • Gilenya®
  • Glatopa®
  • Rebif®

The Metrics of Successful Therapy

HPC understands that ensuring that patients with multiple sclerosis have access to the most advanced medication therapies is only one component of their treatment.

Our comprehensive system of care combines our comprehensive pharmacy services with other clinical and administrative services to help patients improve their quality of life and achieve the best possible outcomes from their therapy.

From care coordination and collaborative planning with the patient’s medical team to our home-based nursing services that specialize in administering injectable and IV drugs, HPC offerings add up to positive outcomes.

Learn More

For more information on Multiple Sclerosis, please visit the following sites:

Translate »